GWN Securities Inc. bought a new position in shares of Amdocs Limited (NASDAQ:DOX – Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund bought 8,649 shares of the technology company’s stock, valued at approximately $738,000.
Several other hedge funds and other institutional investors have also added to or reduced their stakes in DOX. Atria Investments Inc grew its position in Amdocs by 7.2% during the third quarter. Atria Investments Inc now owns 9,408 shares of the technology company’s stock worth $823,000 after buying an additional 634 shares in the last quarter. OneDigital Investment Advisors LLC purchased a new position in Amdocs during the third quarter worth about $223,000. Empowered Funds LLC grew its position in Amdocs by 23.7% during the third quarter. Empowered Funds LLC now owns 13,105 shares of the technology company’s stock worth $1,146,000 after buying an additional 2,510 shares in the last quarter. Natixis Advisors LLC boosted its holdings in shares of Amdocs by 1.3% in the 3rd quarter. Natixis Advisors LLC now owns 27,592 shares of the technology company’s stock worth $2,414,000 after purchasing an additional 346 shares in the last quarter. Finally, Seizert Capital Partners LLC boosted its holdings in shares of Amdocs by 19.1% in the 3rd quarter. Seizert Capital Partners LLC now owns 490,655 shares of the technology company’s stock worth $42,922,000 after purchasing an additional 78,773 shares in the last quarter. 92.02% of the stock is currently owned by hedge funds and other institutional investors.
Amdocs Price Performance
DOX opened at $87.99 on Monday. The stock’s 50 day simple moving average is $86.71 and its 200 day simple moving average is $87.08. The company has a debt-to-equity ratio of 0.22, a current ratio of 1.16 and a quick ratio of 1.20. Amdocs Limited has a 1 year low of $74.41 and a 1 year high of $93.34. The firm has a market cap of $9.93 billion, a price-to-earnings ratio of 20.42, a PEG ratio of 1.47 and a beta of 0.68.
Amdocs Increases Dividend
The business also recently declared a quarterly dividend, which will be paid on Friday, April 25th. Investors of record on Monday, March 31st will be given a dividend of $0.527 per share. This represents a $2.11 annualized dividend and a yield of 2.40%. This is a positive change from Amdocs’s previous quarterly dividend of $0.48. The ex-dividend date of this dividend is Monday, March 31st. Amdocs’s dividend payout ratio (DPR) is presently 48.72%.
Wall Street Analysts Forecast Growth
Separately, StockNews.com cut Amdocs from a “strong-buy” rating to a “buy” rating in a report on Friday, February 28th. One investment analyst has rated the stock with a hold rating and five have issued a buy rating to the company’s stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $101.20.
Check Out Our Latest Report on Amdocs
Amdocs Company Profile
Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.
Further Reading
- Five stocks we like better than Amdocs
- Value Investing: Is it a Good Strategy in 2022? (Hint: Always)
- How to Build the Ultimate Everything ETF Portfolio
- Are Penny Stocks a Good Fit for Your Portfolio?
- Dutch Bros or Starbucks: Which Coffee Stock Has More Growth?
- How to invest in marijuana stocks in 7 stepsĀ
- 3 Stocks With High ROE and Market-Beating Growth Potential
Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.